These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24747233)

  • 21. Industry-sponsored clinical research: a double-edged sword.
    Montaner JS; O'Shaughnessy MV; Schechter MT
    Lancet; 2001 Dec; 358(9296):1893-5. PubMed ID: 11741648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uneasy alliance--clinical investigators and the pharmaceutical industry.
    Bodenheimer T
    N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 24. Academia and big pharma United.
    Ljunggren HG
    Sci Transl Med; 2014 Jan; 6(217):217ed1. PubMed ID: 24382892
    [No Abstract]   [Full Text] [Related]  

  • 25. The FDA: Doctors, Investigators, and Translational Research.
    Eaglstein WH
    J Invest Dermatol; 2015 Nov; 135(11):2555-2556. PubMed ID: 26548481
    [No Abstract]   [Full Text] [Related]  

  • 26. A new approach to synergize academic and guideline-compliant research: the CLARITY-BPA research program.
    Schug TT; Heindel JJ; Camacho L; Delclos KB; Howard P; Johnson AF; Aungst J; Keefe D; Newbold R; Walker NJ; Thomas Zoeller R; Bucher JR
    Reprod Toxicol; 2013 Sep; 40():35-40. PubMed ID: 23747832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fostering innovation in medicine and health care: what must academic health centers do?
    Dzau VJ; Yoediono Z; Ellaissi WF; Cho AH
    Acad Med; 2013 Oct; 88(10):1424-9. PubMed ID: 23969357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceuticals and medical devices: FDA oversight.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-123. PubMed ID: 24482893
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA and EMEA pool scientific advice.
    Katsnelson A
    Nat Biotechnol; 2004 Dec; 22(12):1490-1. PubMed ID: 15583642
    [No Abstract]   [Full Text] [Related]  

  • 30. Perestroika in pharma: evolution or revolution in drug development?
    FitzGerald GA
    Mt Sinai J Med; 2010; 77(4):327-32. PubMed ID: 20687177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA user fees and innovation.
    Somberg J
    Am J Ther; 2008; 15(2):97. PubMed ID: 18356626
    [No Abstract]   [Full Text] [Related]  

  • 32. From bench to FDA to bedside: US regulatory trends for new stem cell therapies.
    Knoepfler PS
    Adv Drug Deliv Rev; 2015 Mar; 82-83():192-6. PubMed ID: 25489841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A roadmap for academic health centers to establish good laboratory practice-compliant infrastructure.
    Adamo JE; Bauer G; Berro M; Burnett BK; Hartman KA; Masiello LM; Moorman-White D; Rubinstein EP; Schuff KG
    Acad Med; 2012 Mar; 87(3):279-84. PubMed ID: 22373618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How academic labs can approach the drug discovery process as a way to synergize with big pharma.
    Loregian A; Palù G
    Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outsourcing challenges FDA to strengthen oversight abroad.
    Torres C
    Nat Med; 2010 Feb; 16(2):139. PubMed ID: 20134448
    [No Abstract]   [Full Text] [Related]  

  • 36. Advancing the education mission.
    Kanter SL
    Acad Med; 2012 Aug; 87(8):991-2. PubMed ID: 22827976
    [No Abstract]   [Full Text] [Related]  

  • 37. Research Projects Supported by the University of California, San Francisco-Stanford Center of Excellence in Regulatory Science and Innovation.
    Giacomini KM; Lin L; Altman RB
    Clin Pharmacol Ther; 2019 Apr; 105(4):815-818. PubMed ID: 30773618
    [No Abstract]   [Full Text] [Related]  

  • 38. "Hood ornament" or "V-10 engine"? Myths and realities regarding physician-scientists in academic radiation oncology departments.
    Kao GD; McKenna WG
    J Am Coll Radiol; 2004 Aug; 1(8):539-44. PubMed ID: 17411649
    [No Abstract]   [Full Text] [Related]  

  • 39. Strategic planning and entrepreneurism in academic health centers.
    Smith CT
    Hosp Health Serv Adm; 1988; 33(2):143-52. PubMed ID: 10302489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Millennium collaborates with leading clinical centers.
    Hodgson J
    Nat Biotechnol; 1998 Oct; 16(10):897. PubMed ID: 9788331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.